Introduction
Thrombocytopenia, disseminated intravascular coagulation, and shock are complications of bacteremia due to endotoxin-producing gram-negative rods, a cause of significant morbidity and mortality with an estimated 18,000 deaths in the United States per year (1) . It has been established that the toxic principle of endotoxin is lipid A, which is responsible for induction of fever, macrophage activation, mitogenic lymphocyte stimulation, complement activation, hemorrhagic skin necrosis, and gelation of Limulus amebocyte extract (2, 3) . Lipid A is composed of a disaccharide with amide-and ester-linked fatty acid residues. The latter consist of hydroxymyristic, lauric, palmitic, and myristic acids. The presence of these fatty acids and phosphate group is required for the biologic activity of lipid A (4). Its precursor, lipid X, is diacyl-N-glucosamine 1-phosphate containing hydroxymyristoyl residues (5) . Lipid A with the myristoxymyristic acid-containing part resembles phorbol 1 2-myristate 13-acetate (PMA) (Fig. 1) . PMA is a known agonist of platelets (6, 7) and an activator of protein kinase C (8) .
Protein kinase C is a phospholipid-and calcium-dependent enzyme of apparent Mr 82,000 that occurs in tissues of a large number of species, ranging from annelida to mammalia (9-1 1). The inactive form ofthe enzyme is particularly susceptible to activation by diacylglycerol generated by the action of phospholipase C (12) . Then, protein kinase C forms a quarternary complex with diacylglycerol, calcium, and phosphatidylserine in the membrane (13) . The enzyme is also activated by the calcium-dependent neutral protease (calpain), present in platelet cytoplasm (14) . Protein kinase C phosphorylates seryl and threonyl but not tyrosyl residues in cellular proteins ( 15) . In human platelets the main protein phosphorylated by kinase C is a protein of Mr 40,000-47,000, which was initially described by Lyons et al. (16) and established as a marker of protein kinase C activation in platelets by Takai and colleagues ( 17) . The recent report that this protein is a specific phosphatase for inositol triphosphate (UP3),' inositol triphosphate 5'-phosphomonoesterase, (18) , indicates its important role in regulation of the intracellular level of IP3, a key messenger for mobilization of calcium from intracellular stores (19) . Phosphorylation of P47 is observed in response to several known agonists of platelets such as thrombin, collagen, epinephrine, and platelet activating factor (16, (20) (21) (22) . We observed that mutant Re595 of Salmonella minnesota, bearing lipid A and a unique sugar, 2-keto-3-deoxyoctonate (KDO), but deficient in oligosaccharides, stimulates human platelets. This stimulation was accompanied by phosphorylation of P47 (23). Wightman and Raetz reported that both lipid A and its precursor, lipid X, activate protein kinase C in a murine macrophage cell line (24) . In this study we show that lipid A, but not lipid X, stimulates human platelets. Modulation of protein kinase C in human platelets by lipid A is an important attribute of this toxic principle of lipopolysaccha- Preparation of lipid A, lipid X, and PMA. Lipid A (CalbiochemBehring Corp., La Jolla, CA), prepared by acid hydrolysis of LPS from Salmonellaminnesota Re595 and containing less than 0.1% KDO, and lipid X (Lipidex, Middleton, WI) were suspended in distilled water (2 mg/ml). Triethylamine (TEA) was added to have final concentration 0.1%. The concentration of TEA in the platelet test sample was from 0.001 to 0.005%. PMA was dissolved inDMSO (10 mg/ml) and diluted to have100 ng PMA/Igl DMSO. The concentration of DMSO in the platelet incubation mixture did not exceed 0.5%. Parallel controls of diluents were run in the platelet incubation mixture for all experiments.
Secretion of ['4C]serotonin from human platelets. Platelet-rich plasma (PRP) was loaded with [14C]serotonin (0.05 MCi/ml) and then platelets radiolabeled with serotonin were separated from free amine and from plasma proteins as described previously (26) . Secretion of ['4C]serotonin was measured at 370C with stirring for the specified times in the presence of imipramine (1.5 Mg/ml). The reaction was stopped by chilling the platelets on ice and adding 0.3% p-formaldehyde in 2 mM EDTA before centrifugation in a microcentrifuge for 15,000 g for 2 min (27) . Secretion was calculated as previously described (26) .
Platelet aggregation was done at 370C with stirring according to the method of Born (28), using platelets separated from plasma proteins as described above and monitored in a dual channel aggregometer (Payton Associates, Buffalo, NY). Aggregation was measured using percent maximum transmission (T,,) and slope value, which represented the change per one minute along a tangent line to the steepest increase in light transmission (25) .
Phosphorylation ofhuman platelet proteins. Human platelets, separated from plasma proteins, were incubated with 32p04 ( 15 ,ug ofstandard unlabeled phosphatidic acid was added.
A TLC solvent system of chloroform/methanol/water/ammonium hydroxide (60:38:4:2, vol/vol) was used for resolution of phospholipids, which were visualized with iodine vapor and autoradiography was performed as above (31) . The spots at the points of the phosphatidic acid standard were scraped into a liquid scintillation vial, methanol was added to elute the [32P]phosphatidic acid, and its radioactivity was counted by liquid scintillation using Aquasol-2.
[3H]Diacylglycerol generation and detection. Platelet-rich-plasma (PRP) from 100 ml of human blood was incubated with [3H]-arachidonic acid (3H-AA) (220 Ci/mmol) in final concentration 34 MCi/30 ml PRP at 370C for 60 min. 3H-AA-labeled platelets were separated from plasma proteins as described above using siliconized glassware in all steps. Samples of platelets (2 X 108 platelets/ml) were incubated with different agonists for various times at 370C with stirring. Incubation was stopped by adding 3.75 vol of ice-cold chloroform/methanol (1/2, vol/vol). Lipid extractions were done as described in the phosphatidic acid detection method. After drying, the samples were dissolved in 30 Ml of CHC13 and 10 Mg of 1,2-diolein (Sigma Chemical Co., St. Louis, MO) was added to each sample as a standard.
Lipids were separated on the TLC plates characterized above using a two solvent system described by Skipski et al. (32) . The (Fig. 3, upperpanel) . A similar pattern of rapid phosphorylation was observed with 0.3 gM PMA (Fig. 3, lower panel) phosphatidic acid (Fig. 6 ). In contrast, thrombin induced rapid and transient formation of diacylglycerol followed by the generation of phosphatidic acid (Fig. 6 ). Thrombin also caused production of TXB2, whereas lipid A-stimulated platelets did not produce TXB2 measured by radioimmunoassay (results not shown).
Lipid X inhibits stimulation of human platelets by endotoxic lipid A and PMA. Biosynthesis of endotoxic lipid A involves a series of structural precursors. One of them, derived from Escherichia coli, is lipid X (N2,03-diacylglucosamine 1-phosphate), which was shown to share some biologic properties of lipid A, exemplified by mitogenic stimulation of B lymphocytes and gelation of the Limulus lysate (5, 35) but not toxicity to chick embryos and pyrogenicity in rabbits (36) . In our experiments with human platelets, lipid X did not induce of ['4C]serotonin secretion (Fig. 7) . However, lipid X preincubated with platelets for 5 min at room temperature without stirring inhibited ['4C]serotonin secretion from human platelets induced by lipid A or PMA (Fig. 7) . The inhibitory effect of lipid X was concentration-dependent. 50% of inhibition of the lipid A-mediated secretion of ['4C]serotonin was observed at almost equimolar concentration of lipid X and complete inhibition was achieved at 4-5 M excess of lipid X. Secretion of ['4C]serotonin from platelets by PMA was also inhibited, whereas that induced by thrombin (0.02 U/ml) was not blocked by lipid X in concentration range tested (Fig. 7) .
Using similar conditions, lipid X inhibited activation of protein kinase C in human platelets stimulated with lipid A, PMA, and thrombin, as shown by suppressed phosphorylation of P47 (Fig. 8) . Since a rise in platelet cyclic AMP blocks several stimulatory pathways in platelets (37) , it was important to examine whether lipid X influences adenylate cyclase in a human platelet membrane preparation. As shown in Fig. 9 , lipid X did not activate adenylate cyclase, whereas prostaglandin I2 (prostacyclin) did. Thus, the inhibitory effect of lipid X on lipid A-induced secretion of ['4C]serotonin and phosphorylation of P47 does not appear to be mediated by an increase in cyclic AMP.
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